BRIEF-Oncodesign says option to license rights for Parkinson Program from Ipsen

* Oncodesign announces return of research collaboration and option to license rights for parkinson program from Ipsen
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.